China Resources Boya Bio-pharmaceutical Group Co., Ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | China Resources Boya Biopharmaceutical Group Co., Ltd. (stock abbreviation: Boya Biotech, stock code: 300294) was founded in 1993. It is the blood product platform of China Resources Health and the only blood product production enterprise in Jiangxi Province. It mainly engages in blood product business and is a comprehensive pharmaceutical industry group that integrates biochemical drugs, chemical drugs, raw materials, etc. It is one of the few people in the country with blood albumin, human immunoglobulin One of the enterprises with complete products in the three major categories of coagulation factors. China Resources Boya Biology has 6 member enterprises, 14 plasma collection stations, and its industry spreads all over Jiangxi, Guangdong, Jiangsu, Sichuan, Beijing, Guizhou, Shanxi, Hainan and other places. Its products include blood products, diabetes and anti infective chemicals, biochemical drugs, etc., with more than 90 varieties and nearly 200 specifications. Its core product, human fibrinogen, has a leading position in terms of yield and market share in China. The company is a national high-tech enterprise and a national enterprise technology center, with a Jiangxi Blood Products Engineering Research Center and a postdoctoral research workstation. It has over 200 authorized patents and has extensive cooperation with well-known drug research and development institutions and universities both domestically and internationally in terms of technology exchange and product development. The company has won honors such as Forbes China's Top 100 Listed Companies, Jiangxi May Day Labor Award, Jiangxi Province Science and Technology Progress Award First Prize, Jiangxi Province Jinggang Quality Nomination Award, Jiangxi Province Labor Relations Harmony Award, Jiangxi Province "Thousand Enterprises Help Thousand Villages" Precision Poverty Alleviation Action Advanced Enterprise, Jiangxi Province Red Cross Humanitarian Rescue Honorary Unit, Jiangxi Province Anti epidemic Contribution Enterprise, etc. In the future, China Resources Pharmaceuticals will use China Resources Boya Biotechnology as the blood product platform of China Resources Health, promote the integration of resources in the domestic blood product industry, and build China Resources Boya Biotechnology into a world-class blood product enterprise. CR Boya Biotech will fulfill its corporate mission of "transmitting love and life", striving to protect human health and improve the quality of life. |
| Headquarter | Fuzhou City |
| Establish Date | 11/6/1993 |
| Listed Code | 300294.SZ |
| Listed Date | 3/8/2012 |
| Chairman | Tao Ran. |
| CEO | Liang Xiaoming. |
| Website | www.china-boya.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
